ABSTRACT Two human neurophysins have been purified from acetone-desiccated posterior pituitaries by acidic extraction, molecular sieving, and ion-exchange chromatography. The complete amino acid sequence of each protein has been determined by using a sequencer and characterizing two sets of overlapping enzymic peptides. The two neurophysins belong to two structural families previously defined as MSEL-and VLDV-neurophysins according to the nature of the residues in positions 2, 3, 6, and 7.
Neurophysins are small proteins found associated with neurohypophysial hormones in stoichiometric and reversible complexes (1) . Isolation of neurophysins and neurohypophysial hormones from several mammalian species has been carried out often through this complex procedure (2) .
Purification of human neurophysins has been attempted previously by using either by-products of the gonadotropin purification (3) or directly from acetone-desiccated posterior pituitary glands (4, 5) . Proteins are usually extracted by 0.1 M HCI at 4°C; after fractionation by molecular sieving, the crude neurophysins of Mr 10,000 are subjected to ion-exchange chromatography in order to isolate the different types of neurophysins (4, 5) . Purification also has been carried out by using continuous polyacrylamide gel electrophoresis (6) (7) (8) . Neuro- physins are often termed neurophysin I, II, III, etc. according to their migrations to the anode, but this identification is confused by the presence of truncated forms. Therefore, another nomenclature, based upon the nature of the amino acids in positions 2, 3, 6, and 7, has been proposed, and two chemical types of neurophysins, termed MSEL-and VLDV-neurophysins, have been distinguished (9) . (MSEL-neurophysins contain methionine-2, serine-3, glutamic acid-6, and leucine-7; VLDV-neurophysins contain valine-2, leucine-3, aspartic acid-6, and valine-7.) In each mammalian species, one protein of each type has been discovered.
Preliminary results on the NH2-terminal amino acid sequences of human neurophysin I or VLDV-neurophysin (5, 6, 10) and neurophysin II or MSEL-neurophysin (8, 10) Extraction was usually carried out with fractions of 1 g of material. Each sample was extracted with 0.1 M HCl (50 ml/ g) for 4 hr at 40C. After centrifugation, the supernatant solution was directly subjected to a molecular sieving by passage through a column (2.5 x 170 cm) of Sephadex G-75 equilibrated with 0.1 M formic acid. Fractions (3-ml) were collected, and absorbance at 280 nm was measured. Five peaks were detected; the fourth (D), containing proteins of Mr 11,000 as estimated by sodium dodecylsulfate/polyacrylamide gel electrophoresis (13) , was used for further purification.
This "crude neurophysin" fraction was freeze-dried, and the material (30-40 mg) was chromatographed onto a column (0.4 x 0.50 cm) of DEAE-Sephadex A-50 by using a discontinuous ionic strength gradient (0.15 M to 1 M) of pyridine acetate (pH 5.9). Fractions (1-ml) were collected, and proteins were estimated with Folin-Lowry reagent (14) . In a typical experiment carried out with 33.5 mg of crude neurophysins, about 10.5 mg of material was not retained on the column; MSEL-neurophysin was recovered between 142-184 ml (2.7 mg); VLDV-neurophysin, between 185-300 ml (5 mg); VLDV-neurophysin with contamination, between 300-400 ml (9.9 mg); and MSEL-neurophysin with a four-residue COOH-terminal truncation, between 452-568 ml (5.4 mg). Homogeneity was checked by disc polyacrylamide gel electrophoresis. The overall recovery in proteins was 83%, neurophysins representing 68% of the material subjected to ion-exchange chromatography and 81.5% of the recovered proteins.
Amino Acid Sequences. Both neurophysins were either oxidized by performic acid (15) or reduced by dithiothreitol and
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. alkylated with iodoacetamide (16) (17) , and resulting peptides were separated by peptide mapping on Whatman 3MM paper under conditions as described (18) . Peptides were numbered as in Chauvet et al (18) . Peptides, after acid hydrolysis (6 M HCI for 48 hr at 105TC in sealed evacuated tubes), were analyzed on a Spinco model 120 B amino acid analyzer fitted with a high-sensitivity cell (19) . Amino acid sequences of peptides were determined.by a manual Edman procedure (20) either directly for small peptides or after (i) cleavage by subtilisin, chymotrypsin, elastase, or staphylococcal proteinase, (ii) isolation of subfragments, and (iii) determination of their sequences.
On the other hand, alkylated proteins also were subjected to automated degradation (21) in a SOCOSI model P 110 sequencer under conditions as described (18) . Phenylthiohydantoin amino acids were identified by TLC (22) . .'acid compositions of tryptic peptides (T1-T8) and staphylococcal proteinase peptides (St1-St8) were determined. They account for a 93-residue polypeptide chain. Substitution of the usual Pro-60 by an alanine residue allows an additional tryptic cleavage at the level of the bond between Lys-59 and Ala-60 so that two tryptic peptides, T5 and T5', were found instead of the usual single T5 identified in MSEL-neurophysins of the other species (18) .
Amino acid sequences were determined either directly or on subfragments. Tryptic and staphylococcal proteinase peptides overlap: St1 gives the alignment T1-T2-T3-T4; St4, the alignment T4-T5; St5, the alignment T5-T5'-T6; St7, the alignment T6-T7; and St8, the alignment T7-T8. The data permitted the determination of the complete sequence (Fig. 1) .
Amino Acid Sequence of Human VLDV-Neurophysin. Amino acid compositions of tryptic (T1-T6) and staphylococcal pro- Ala-Leu-Arg-Cys-Gln-Glu-Glu-Asn-Tyr-Leu-Pro-Ser-Pro-Cys-Gln-Ser-oGly-Gln-Lys-Pro Cys-Gly-Ser-Gly-Gly-Arg-Cys-Ala-Ala-Ala-Gly-I le-Cys-Cys-Ser-Pro-Asp-Gly-Cys-His Amino acid sequences were determined either directly for the shorter fragments or with the help of the subfragments for the longer fragments. Staphylococcal proteinase peptides allowed the alignment of tryptic peptides: St1 for the alignment T1-T2-T3-T4, St3 for T4-T5, and St4 for T5-T5'-T6. The complete sequence of human VLDV-neurophysin is given in Fig.   2 Compared with bovine VLDV-neurophysin (Fig. 2) there are 11 substitutions-2 in the "inter-family variable" sequence [1] [2] [3] [4] [5] [6] [7] [8] [9] 6 in the invariant sequence [namely, in positions 25 (Asn/Ser), 29 (Ala/Gly), 30 (Glu/Asp), 69 Although the COOH-terminal Gln-93 can be missing in some human samples, the five VLDV-neurophysins [namely, ox (28) , pig (28) , horse (29) , rat (27) , and man] characterized to date have 93 residues. In contrast to the MSEL-neurophysin family, no basic residue(s) is found near the COOH-terminal end, and, therefore, the putative processing enzyme that liberates VLDVneurophysin from a precursor may have a specificity different from that of the processing enzyme of MSEL-neurophysin precursors. However, these basic residues may have been removed by a carboxypeptidase B after cleavage of the precursor, as observed for proinsulin (30) .
Comparison Between Human MSEL-and VLDV-Neurophysins. When the two human neurophysins are compared, 26 variations are found, and this figure is significantly higher than the one found for the other mammals (about [19] [20] [21] [22] [23] . There are five substitutions in the distinctive NH2-terminal sequence 1-9, five in the invariant sequence 10-74, and 16 in the variable COOH-terminal sequence 75-93, with only Cys-74, Pro-83, and Cys-85 remaining constant (Fig. 3) . This latter part of the molecule is clearly more subjected to variations than are the NH2-terminal and central regions.
An unexpected finding is the same substitution in both neurophysins in position 60: proline is replaced by alanine. All the other known neurophysins have a proline residue in this position. In the same way, in position 29, glycine is replaced by alanine in both neurophysins. In the rat the same replacement of glycine by alanine in position 29 was also observed in both neurophysins (27) . It is tempting to assume that a single deoxynucleotide sequence encodes for the central part 10-74 of both neurophysins and that the differential NH2-and COOH-terminal parts are added by different splicings. However, when compared with the usual sequence 10-74, positions 30 [8-arginine] vasopressin, a linking sequence Gly-Lys-Arg, the MSEL-neurophysin previously identified (23) , an arginine residue, and a 39-residue glycopeptide previously identified in bovine extract (34) . It can be assumed that oxytocin and VLDV-neurophysins are fragments of a similar common precursor.
Human neurohypophysial hormones have been isolated by Light and du Vigneaud (35) , using the neurophysin complex procedure of Acher et al. (36) ; oxytocin and arginine vasopressin have been identified by qualitative amino acid composition determined after a two-dimensional paper chromatography (35) .
The human oxytocic and vasopressor peptides now have been isolated by two successive molecular sievings on Sephadex G-75 and Bio-Gel P-4, followed by paper chromatoelectrophoresis (20) , and their quantitative amino acid compositions are in agreement with those of oxytocin and [8-arginine] (12, 32) . A duplication of the ancestral gene, assumed to have likely occurred between cyclostomes and bony fishes (2), gave two structurally related polypeptides subjected to independent mutations. Apparently mutations were rare in the hormonal moiety of the precursors because, for instance, all the bony fishes have isotocin and vasotocin, all nonmammalian tetrapods have mesotocin and vasotocin, and virtually all placental mammals have oxytocin and [8-arginine] vasopressin. The neurophysin moiety seems to have, in mammals, a nearly invariant central part. The NH2-terminal part (residues 1-9) appears to distinguish the vasopressin-associated neurophysin (MSEL-neurophysin) from the oxytocin-associated neurophysin (VLDV-neurophysin). If this part is virtually invariant in the MSEL-neurophysin family, some substitutions occur in the VLDV-neurophysin family, particularly in position 2 that can be valine or alanine. In human VLDVneurophysin, positions 2 and 3 are occupied by alanine and proline, respectively, instead of valine and leucine found usually. However, on one hand, residues 6, 7, and 9 are those of the VLDV-neurophysins; on the other hand, the COOH-terminal sequence (residues 75-93) shows clearly the similarity with the VLDV-neurophysin family (Fig. 2) .
The question is whether the two types of neurophysins could be recognized in lower vertebrates. If, for instance, a MSELneurophysin shares the same precursor with vasotocin, and a VLDV-neurophysin shares the same precursor with mesotocin, the two putative evolutionary filiations vasotocin-vasopressin and mesotocin-oxytocin would receive great support.
